SCHEMBL17295267

SCHEMBL17295267

O=C1C(=Cc2ccc3c(c2)OCCO3)SC(=NCc2ccc(F)cc2)N1c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 12/20 0.47
▸ S1PR3 Q99500 12/20 0.47
▸ CFTR P13569 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ DYRK2 Q92630 2/20 0.42
▸ PIM1 P11309 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ FAAH O00519 1/20 0.42
▸ DYRK3 O43781 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295265 1.00 S1PR1 (0.47) S1PR1S1PR3CFTRCA9DYRK2
SCHEMBL19096377 0.96 S1PR1 (0.45) S1PR1S1PR3CFTRCA9DYRK2
SCHEMBL19096625 0.95 CFTR (0.47) S1PR1S1PR3CFTRCA9DYRK2
SCHEMBL17302125 0.93 S1PR1 (0.51) S1PR1S1PR3CFTRCA9DYRK2
SCHEMBL19096607 0.91 MGAM (0.46) S1PR1S1PR3CFTRCA9DYRK2
SCHEMBL19096247 0.91 MGAM (0.46) S1PR1S1PR3CFTRDYRK2PIM1
SCHEMBL19096567 0.89 FAAH (0.49) S1PR1S1PR3CFTRDYRK2PIM1
SCHEMBL19096576 0.89 S1PR1 (0.55) S1PR1S1PR3CFTRALDH1A1MAPT
SCHEMBL19096569 0.86 MEN1 (0.54) S1PR1S1PR3CA9ALDH1A1MAPT
SCHEMBL19096404 0.85 S1PR1 (0.52) S1PR1S1PR3CFTRCA9DYRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback